Evidence map›Paper›PMID 28690143›Full record

ArticleNeurobiology of disease2017

The brain-penetrant 5-HT

Mirko Santello, Alberto Bisco, Natalie Elisabeth Nevian, Enza Lacivita, Marcello Leopoldo, Thomas Nevian

Open access · hybridAbstract read
In one paragraph

Article in Neurobiology of disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Novel Dual 5-HTPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Roles of funny HCN.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2025
    Review
  4. Common and contrasting effects of 5-HTergic signaling in pyramidal cells and SOM interneurons of the mouse cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Spinal Nerve Axotomy: Effects on IInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Targeting Prefrontal Cortex Dysfunction in Pain.The Journal of pharmacology and experimental therapeutics · 2024
    Review
  8. Serotonergic 5-HTCurrent neuropharmacology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Efficient Low-Pass Dendro-Somatic Coupling in the Apical Dendrite of Layer 5 Pyramidal Neurons in the Anterior Cingulate Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  18. Experience and sleep-dependent synaptic plasticity: from structure to activity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mirko SantelloDepartment of Physiology, University of Bern, Bühlplatz 5, 3012 Bern, Switzerland; Institute of Pharmacology and Toxicology, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland; Neuroscience Center Zurich, University of Zurich and ETH Zurich, 8057 Zurich, Switzerland. Electronic address: mirko.santello@pharma.uzh.ch.
Alberto BiscoDepartment of Physiology, University of Bern, Bühlplatz 5, 3012 Bern, Switzerland.
Natalie Elisabeth NevianDepartment of Physiology, University of Bern, Bühlplatz 5, 3012 Bern, Switzerland.
Enza LacivitaDepartment of Pharmacy - Drug Science, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.
Marcello LeopoldoDepartment of Pharmacy - Drug Science, University of Bari Aldo Moro, Via Orabona 4, 70125 Bari, Italy.
Thomas NevianDepartment of Physiology, University of Bern, Bühlplatz 5, 3012 Bern, Switzerland; Center for Cognition, Learning and Memory, University of Bern, Bern, Switzerland. Electronic address: nevian@pyl.unibe.ch.
University of Bern · CHUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic pain is a debilitating pathological condition of high clinical relevance. Changes in neuronal excitability in the anterior cingulate cortex (ACC) play a central role in the negative emotional and affective aspects of chronic pain. We evaluated the effects of LP-211, a new serotonin-receptor-type-7 (5-HT

Indexed as

AffectAnalgesics, Non-NarcoticAnimalsAvoidance LearningDendritesDrug Evaluation, PreclinicalEscape ReactionGyrus CinguliHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMaleMice, Inbred C57BLNeuralgiaPain ThresholdPiperazinesPyramidal CellsReceptors, SerotoninAnalgesics, Non-NarcoticHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsN-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamidePiperazinesReceptors, Serotoninserotonin 7 receptorSerotonin Receptor AgonistsAnterior cingulate cortexHCN channelsNeuropathic painPyramidal neuron

Identifiers

PMID28690143
PMCPMC5560654
OpenAlexW2730135204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.